AcelRx Pharmaceuticals, Inc. (ACRX) Social Stream



AcelRx Pharmaceuticals, Inc. (ACRX): $0.86

0.06 (+7.50%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

ACELRX PHARMACEUTICALS INC (ACRX) Price Targets From Analysts

Use the tables below to see what analysts covering ACELRX PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-17 3 $9 $4 $6 $0.768 681.25%
2021-11-16 3 $9 $4 $5.833 $0.768 659.51%
2021-12-02 2 $4.5 $4 $4.166 $0.768 442.45%
2022-03-11 3 $4.5 $4 $4.166 $0.768 442.45%
2022-08-12 2 $4 $4 $4 $0.768 420.83%
2022-11-15 1 $80 $80 $80 $0.768 10316.67%
2023-04-03 2 $80 $80 $80 $0.768 10316.67%
2023-08-18 1 $8 $8 $8 $0.768 941.67%
2023-09-25 1 $5 $5 $5 $0.768 551.04%
2023-11-09 1 $5 $4.25 $4.625 $0.768 502.21%
NA 1 $NA $NA $NA $0.768 NA%

Price Target Last Issued August 18, 2023

The Trend in the Analyst Price Target


ACRX's average price target has moved down $1.38 over the prior 26 months.

Over the past 31 weeks, ACRX's average upside potential has been 3,238.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-03 2 80 80.00 80.000 0.610 13014.75%
2023-08-18 1 8 8.00 8.000 0.869 820.6%
2023-09-25 1 5 5.00 5.000 0.601 731.95%
2023-10-02 1 5 4.25 4.625 0.550 740.91%
2023-11-09 1 5 4.25 4.625 0.470 884.04%

ACRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


ACRX's average broker recommendation rating improved by 1 over the prior 15 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ACELRX PHARMACEUTICALS INC's number of analysts covering the stock is greater than 30.63% of all US stocks.
  • ACRX has a greater upside potential (average analyst target price relative to current price) than 957.38% of all US stocks.
  • In terms of how ACELRX PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -59.42% of that group.
  • ACRX has a greater average analyst price target than 280.64% of stocks in the small market cap category.

Stocks similar to ACELRX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IBIO, AMPE, and VTGN.

What is the outlook for ACRX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!